Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data.

Area of Science:

• Pharmacovigilance
• Health Informatics
• Information Technology in Healthcare

Background:

• Drug safety monitoring is crucial in clinical practice and beyond.
• Existing systems require advanced IT solutions for efficient adverse drug reaction (ADR) investigation.
• The PVClinical project addresses the need for specialized IT support in pharmacovigilance.

Purpose of the Study:

• To outline the development of an IT platform, PVClinical, for investigating potential ADRs.
• To detail the integration of OMOP-CDM and OHDSI software stack within the PVClinical platform.
• To demonstrate the utility of these tools for drug safety analytics.

Main Methods:

• Utilizing the Observational Medical Outcomes Partnership - Common Data Model (OMOP-CDM) for data integration from Electronic Health Records (EHRs).
• Employing the Observational Health Data Sciences and Informatics (OHDSI) open-source software stack for data analysis.
• Integrating diverse EHR data including patient demographics, encounters, diagnoses, drugs, and procedures into a standardized format.

Main Results:

• The OMOP-CDM facilitates the integration of heterogeneous EHR data.
• The OHDSI stack provides efficient analytical tools for drug safety inquiries.
• The PVClinical platform enables rapid investigation of potential adverse drug reactions.

Conclusions:

• The integration of OMOP-CDM and OHDSI within the PVClinical platform offers a robust solution for drug safety.
• This approach enhances the ability to identify and investigate potential adverse drug reactions efficiently.
• IT solutions are pivotal for advancing pharmacovigilance processes in healthcare settings.